You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-BDNF antibody (ab6201)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab6201? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab6201 has been referenced in 6 publications.

  1. Côté MP et al. Activity-dependent increase in neurotrophic factors is associated with an enhanced modulation of spinal reflexes after spinal cord injury. J Neurotrauma 28:299-309 (2011). WB; Rat. PubMed: 21083432
  2. Mashayekhi F et al. Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease. J Clin Neurosci 17:623-7 (2010). WB; Human. PubMed: 20189394
  3. Salehi Z & Mashayekhi F Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease. J Clin Neurosci 16:90-3 (2009). PubMed: 19017558
  4. Izal-Azcarate A et al. Immunohistochemical characterization of the rat carotid body. Respir Physiol Neurobiol 161:95-9 (2008). Rat. PubMed: 18280799
  5. Ulmann L et al. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 28:11263-8 (2008). IHC-FoFr; Mouse. PubMed: 18971468
  6. Maier K et al. Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study. Am J Pathol 169:1353-64 (2006). PubMed: 17003491

Publishing research using ab6201? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"